Antivirals for influenza;Traitements anti-viraux au cours de la grippe

Bulletin de l'Academie Nationale de Medecine

Volumn 189, Issue 2, 2005, Pages 341-357

  Leophonte, Paul ^a   Bourel, M Michel ^b   Delaveau, M Pierre ^b   Nordmann, M Roger ^b   Dubois, M Gérard ^b   Guéniot, M Maurice ^b   Michel Briand, M Yvon ^b  

^a SERVICE DE PNEUMOLOGIE   (France)

^b NONE

Author keywords

Antivirals agent; Endemic diseases; Influenza

Indexed keywords

EID: 22544452114     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)33588-5     Document Type: Article

References (45)

1. MANUGUERRA JC., VAN DER WERF S. - Les antiviraux contre la grippe. Virologie, 1999, 3, 439-52.
2. LINA B. - Physiopathologie de l'infection et de ses complications. In : La grippe : conceptions actuelles. Hannoun G., Léophonte P., Peyramond D., eds : John Libbey eurotext pub., 2003, 43-63.
3. AOKI FY. - Amantadine et Rimantadine. In : Nicholson KG. Webster RG. Hay AJ., Textbook of influenza. Oxford : Blackwell Science Ltd ., 1998, 457-76.
4. SEARS S., CLEMENT M. - Protective efficacy of low-dose amantadine in adults challenged with wild-type influenza A virus. Antimicrob. Agents Chemother., 1987, 31, 1470-3.
5. MONTO AS. - Guidelines for the clinical use of antivirals. In : Nicholson KG. Webster RG. Hay AJ. Textbook of influenza. Oxford : Blackwell Science Ltd, 1998, 506-14.
6. HAYDEN FG. - Antivirals for pandemic influenza. J. Infect. Dis., 1997, 176, S56-61.
7. ENGLUND J., CHAMPLIN R., WYDE PR., KANTARJIAN H., ATMAR RL., TARRAND J., YOUSUF H., REGNERY H., KLIMOV A.I., COX N.J., WHIMBEY E. - Common emergence of amantadine and rimantadine resistant influenza A viruses in symptomatic immunocompromised patients. Clin. Infect. Dis., 1998, 26, 1418-24.
8. HAYDEN FG. - Amantadine and Rimantadine. Clinical aspects. In : Richman DG. Antiviral drug resistance. John Wiley and sons Ltd 1996, 44, 59-77.
9. FREYMUTH F., VABRET A. - Médicaments actifs contre les virus respiratoires. Rev. Prat., 1997, 47, 646-51.
10. LAMBKIN R., OXFORD IS. - Alternative antiviral agents. In : Nicholson KG. Webster RG. Hay AJ. Textbook of influenza. Oxford : Blackwell Science Ltd., 1998, 488-505.
11. VANVORIS L.P., NEWELL P.M., - Antivirals for the chemoprophylaxis and treatment of influenza. Semin. Respir. Infect., 1992, 7, 61-70.
12. KNIGHT V., GILBERT BE. - Ribavirin aerosol treatment of influenza. Infect. Dis. Clin. North. Am., 1987, 1, 441-457.
13. PENN CR. - Inhibitors of influenza virus neuraminidase. In : Nicholson KG. Webster RG. Hay AJ. Textbook of influenza. Oxford : Blackwell Science LTD., 1998, 477-87.
14. KANDEL R., HARTSHORN KL. - Prophylaxis and treatment of influenza virus infection. Biodrugs, 2001, 15, 303-23.
15. BALFOUR HH. - Antiviral drugs. N. Engl. J. Med., 1999, 340, 1255-68.
16. GOVORKOVA EA., LENEVA I.A., GOLOUBEVA O.G. - Comparison of efficacies of RWJ-270201, Zanamivir and oseltamivir against H5N1, H9N2 and other avian influenza viruses. Antimicrob. Ag. Chemother, 2001, 45, 2723-32.
17. MC CAULEY JW., PULLEN LA., FORSYTH M., PENN CR., THOMAS G. - 4-Guanidino-Neu5Ac2en fails to protect chickens from infection with highly pathogenic avian influenza virus, Antiviral research, 1995, 27, 179-86.
18. MCCLELLAN K. - Oseltamivir : a review of its use in influenza. Drugs 2001, 61, 263-83.
19. HAYDEN F.G., OSTERHAUS A.D., TREANOR J.J., FLEMING D.M., AOKI F.Y., NICHOLSON K.G., BOHNEN A.M., HIRST H.M., KEENE O., WIYHTMAN K. - Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infection. N. Engl. J. Med., 1997, 337, 874-80.
20. MIST STUDY GROUP - Randomized trial of efficacy and safety of inhaled zanamivir treatment of influenza A and B virus infections. Lancet, 1998, 352, 1877-81.
21. MAKELA M.J., PAUKSENS K., ROSTILA T., FLEMING D.M., MAN C.Y., KEENE O.N., WEBSTER A. - Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza : a randomized double-blind placebo controlled European study. J. Infect., 2000, 40, 42-8.
22. HEDRICK J.A., BARZILAI A., BEHRE U., HENDERSON F., HAMMOND J., REILLY L., KEENE O. - Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age : a randomized controlled trial. Pediatr. Infect. Dis. J., 2000, 19, 410-7.
23. MONTO A.S., WEBSTER A., KEENE O.N. - Randomized placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B : pooled efficacy analysis. J. Antimicrob. Chemother, 1999, 44, 23-39.
24. OSTERHAUS A., HETRICK J.A., HENRICKSON K.J., MAKELÉ M.J., WEBSTER A., KEENE O.N. - Clinical efficacy of inhaled zanamivir for the treatment of patients with influenza B virus infection. Clin. Drug. Investig., 2000, 4, 223-8.
25. MURPHY K.R., EIVINDSON A., PAUKSENS K., STEIN W.J., TELLIER G., WATTS R., LÉOPHONTE P., SHARP S.J., LOESCHEL E. - Efficacy and safety of inhaled zanamivir for the treatment of influenza in patients with asthma and chronic obstructive pulmonary disease. A double-blind randomised placebo-controlled multicentre study. Clin. Drug. Investig., 2000, 20, 337-49.
26. TREANOR J.J., HAYDEN F.G., VROOMAN P.S., BARBARASH R., BETTIS R., RIFF D., SINGH S., KINNERSLEY N., WARD P., MILLS R.G. - Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza. A randomized controlled trial. JAMA, 2000, 283, 1016-24.
27. NICHOLSON K.G., AOKI F.Y., OSTERHAUS A.D., TROTTIER S., CAREWICZ O., MERCIER C.H., RODE A., KINNERSLEY N., WARD P. - Efficacy and safety of oseltamivir in treatment of acute influenza : a randomized controlled trial. Lancet, 2000, 355, 1845-50.
28. WHITLEY R.J., HAYDEN F.G., REISINGER K.S., YOUNG N., DUTKOWSKI R., IPE D., MILLS R.G., WARD P. - Oral oseltamivir treatment of influenza children. Pediatr. Infect. Dis. J., 2001, 20, 127-33.
29. BOWLES S.K., LEE W., SIMOR A.E., VEARNCOMBE M., LOEB M., TAMBLYN S., FEARON M., LI Y., MCGEER A. - Use of oseltamivir during influenza outbreaks in Ontario nursing homes 1999-2000. J. Am. Geriatr. Soc., 2002, 50, 608-16.
30. KAISER L., WAT C., MILLS T., MAHONEY P., WARD P., HAYDEN F. - Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch. Intern. Med., 2003, 163, 1667-72.
31. MONTO A.S., ROBINSON D.P., HERLOCHER M.L., HINSON J.R. JM., ELLIOTT M.J., CRISP A. - Zanamivir in the prevention of influenza among healthy adults : a randomized controlled trial. JAMA, 1999, 282, 31-5.
32. HAYDEN F.G., ATMAR R.L., SCHILLING M., JOHNSON C., PORETZ D., PAAR D., HUSON L., WARD P., MILLS R.G. - Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N. Engl. J. Med, 1999, 341, 1336-41.
33. PETERS P.H., GRAVENSTEIN S., NORWOOD P., DE BOCK V., VAN COUTER A., GIBBENS M., VON PLATA TA., WARD P. - Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population. J. Am. Geriatr. Soc., 2001, 49, 1025-31.
34. HAYDEN F.G., GUBAREVA L.V., MONTO A.S., KLEIN T.C., ELLIOTT M.C., HAMMOND J.M., SHARP S.J., OSSI M.J. - Inhaled zanamivir for the prevention of influenza in families. N. Engl. J. Med., 2000, 343, 1282-9.
35. WELLIVER R., MONTO A.S., CAREWICZ O., SCHATTEMAN E., HASSMAN M., HEDRICK J., JACKSON H.C., HUSON L., WARD P., OXFORD J.S. - Effectiveness of oseltamivir in preventing influenza in household contacts. A +randomized controlled trial. JAMA, 2001, 285, 748-54.
36. The Medical Letter on drugs and therapeutics. 1999, 21, 107-8.
37. Weekly epidemiological record 2004, 79, 306-8.
38. KISO M., MITAMURA K., SAKAI-TAGAWA Y., VHIRAISHI K., KAWAKAMI C., KIMURA K., HAYDEN F.G., SUGAYA N., KAWAOKA Y. - Resistant influenza A viruses in children treated with oseltamivir : descriptive study, Lancet, 2004, 354, 759-65.
39. HIEN TT., LIEM NT., DUNG NT., SAN LT., MAI PP. et al.. - Avian Influenza A (H5N1) in 10 patients in Viet Nam., N. Engl. J. Med., 2004, 350, 1179-88.
40. UNGCHUSAK K., AUEWARAKUL P., DOWELL FS., KIPHATI R., AUWANIT W., PUTHAVATHANA P., UIPRASERTKUL M., BOONNAK K., PITTAYAWONGANON C., COX NJ., ZAKI SR., THAWATSUPHA P., CHITTAGANPITCH M., KHONTONG R., SIMMERMAN JM., SHOUNSUTTHIWAT S. - Probable person-to-person transmission of avian influenza A (H5N1) N. Engl. J. Med., 2005, 352, 333, 40.
41. es rencontres européennes sur la grippe et sa prevention. Virologie, 2004, 8, 387-91.
42. KENNEY RT., FRECH SA., MUENZ LR., VILLAR CP., MC GLENN GM. - Dose sparing with intradermal injection of influenza vaccine, N. Engl. J. Med., 2004, 351, 2295-301.
43. BELSHE RB., NEWMAN FK., CANNON J., DUANE C., TREANOR J., VANHOECKE C., HOWE BJ., DUBIN G. - Serum antibody responses after intradermal vaccination against influenza, N. Engl. J. Med., 2004, 351, 2286-94.
44. National Vaccine Program Office (NVPO). United States Department of Health Human Services. http : //www.hhs.gov/nvpo/pubs/pandemicflu.htm
45. Plan canadien de lutte contre la pandémie d'influenza. http://www.hc-sc.gc.ca/pphb-dgspsp/cpip-pclcpi/index-f.html